Ray Dalio Idexx Laboratories Inc Transaction History

Bridgewater Associates, LP

$19.6 Billion
Q1 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Bridgewater Associates, LP holds 34,525 shares of IDXX stock, worth $17.2 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

34,525

Previous 58,862 41.35%

Holding current value

$17.2 Million

Previous $32.7 Million 42.94%

% of portfolio

0.1%

Previous 0.18%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$515.08 - $576.87 $12.5 Million - $14 Million	-24,337 Reduced 41.35%	34,525 $18.6 Million
Q4 2023 Feb 14, 2024	SELL	$391.37 - $557.56 $22.7 Million - $32.3 Million	-57,969 Reduced 49.62%	58,862 $32.7 Million
Q3 2023 Nov 13, 2023	BUY	$432.42 - $556.67 $3.93 Million - $5.06 Million	9,096 Added 8.44%	116,831 $51.1 Million
Q2 2023 Aug 11, 2023	BUY	$450.7 - $503.61 $1.97 Million - $2.2 Million	4,363 Added 4.22%	107,735 $54.1 Million
Q1 2023 May 12, 2023	SELL	$406.01 - $514.59 $7.06 Million - $8.95 Million	-17,392 Reduced 14.4%	103,372 $51.7 Million

Q4 2022 Feb 13, 2023	SELL	$324.64 - $441.27 $7.6 Million - $10.3 Million	-23,409 Reduced 16.24%	120,764 $49.3 Million
Q3 2022 Nov 10, 2022	BUY	$325.8 - $407.78 $2.27 Million - $2.84 Million	6,972 Added 5.08%	144,173 $47 Million
Q2 2022 Aug 11, 2022	SELL	$327.37 - $553.44 $733,308 - $1.24 Million	-2,240 Reduced 1.61%	137,201 $48.1 Million
Q1 2022 May 13, 2022	BUY	$466.52 - $631.01 $16.7 Million - $22.6 Million	35,770 Added 34.5%	139,441 $76.3 Million
Q4 2021 Feb 14, 2022	BUY	$586.54 - $666.48 $8.9 Million - $10.1 Million	15,166 Added 17.14%	103,671 $68.3 Million
Q3 2021 Nov 12, 2021	BUY	$621.9 - $705.76 $11.1 Million - $12.6 Million	17,821 Added 25.21%	88,505 $55 Million
Q2 2021 Aug 13, 2021	BUY	$486.36 - $637.08 $14.1 Million - $18.5 Million	28,974 Added 69.47%	70,684 $44.6 Million
Q1 2021 May 14, 2021	SELL	$465.18 - $551.79 $477,739 - $566,688	-1,027 Reduced 2.4%	41,710 $20.4 Million
Q4 2020 Feb 12, 2021	BUY	$383.85 - $499.87 $8.44 Million - $11 Million	21,984 Added 105.93%	42,737 $21.4 Million
Q3 2020 Nov 13, 2020	BUY	$334.54 - $406.31 $6.94 Million - $8.43 Million	20,753 New	20,753 $8.16 Million
Q2 2020 Aug 12, 2020	SELL	$230.66 - $330.16 $623,243 - $892,092	-2,702 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$182.94 - $290.97 $494,303 - $786,200	2,702 New	2,702 $655,000
Q4 2019 Feb 13, 2020	SELL	$248.66 - $285.01 $906,614 - $1.04 Million	-3,646 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$260.07 - $289.93 $948,215 - $1.06 Million	3,646 New	3,646 $991,000
Q1 2019 May 14, 2019	SELL	$178.02 - $225.69 $1.49 Million - $1.88 Million	-8,348 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$176.18 - $248.92 $1.47 Million - $2.08 Million	8,348 New	8,348 $1.55 Million
Q3 2018 Nov 13, 2018	SELL	$218.82 - $254.46 $547,268 - $636,404	-2,501 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$185.56 - $227.9 $555,566 - $682,332	-2,994 Reduced 54.49%	2,501 $0
Q1 2018 May 15, 2018	BUY	$157.81 - $204.73 $867,165 - $1.12 Million	5,495 New	5,495 $1.05 Million
Q4 2017 Feb 13, 2018	SELL	$147.68 - $168.37 $257,406 - $293,468	-1,743 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$150.32 - $166.46 $262,007 - $290,139	1,743	1,743 $271,000

Others Institutions Holding IDXX

# of Institutions

1,213

Shares Held

71.7M

Call Options Held

168K

Put Options Held

394K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $41.4B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account